Patient optimization for surgery relating to Crohn's disease
In this article the authors review the evidence supporting preoperative optimization of patients undergoing surgery for Crohn's disease including strategies that potentially improve surgical outcomes...
View ArticleIQuity's IQIsolate Technology Confirms HardtoDiagnose Autoimmune Disease in...
NASHVILLE Tenn. Oct. 26 2016 PRNewswire IQuity a specialty diagnostics technology company announced that its technology IQIsolate can detect the presence or absence of autoimmune and related...
View ArticleGene Activity Mapping Points to Two Subtypes of Crohn's Disease
Gene activity studies have found that there are two clinically relevant forms of Crohn's disease that are defined by molecular...
View ArticleAvexegen Therapeutics Receives NIH Grant to Develop Treatments for...
Avexegen will use the NIH grant to advance the development of their lead drug candidate Neuregulin4 NRG4 for the treatment of inflammatory bowel disease including Crohn&39;s disease and ulcerative...
View ArticleImmune Pharmaceuticals Receives FDA Guidance for Phase III Pivotal Trial of...
NEW YORK Oct. 27 2016 PRNewswire Immune Pharmaceuticals NASDAQIMNP Immune announced today that it has received guidance from the United States Food and Drug Administration FDA on a phase III study for...
View ArticleNektar to Announce Financial Results for the Third Quarter 2016 on Thursday...
SAN FRANCISCO Oct. 27 2016 PRNewswire Nektar Therapeutics Nasdaq NKTR will announce its financial results for the third quarter ended September 30 2016 on Thursday November 3 2016 after the close of...
View ArticleRobust progress in Q3 2016
Financial results of the first nine months Group revenues increased by 17.8 M to 65.0 M Operating loss reduced by 14.8 M to 48.5 M End of third quarter cash 938.8 M Progress in R&D Start FINCH...
View ArticleAbbVie Reports ThirdQuarter 2016 Financial Results
NORTH CHICAGO Ill. Oct. 28 2016 PRNewswire AbbVie NYSEABBV announced financial results for the third quarter ended September 30 2016. "We delivered another strong quarter with EPS growth ahead of our...
View ArticleNektar Therapeutics Announces Upcoming Presentations at the 2016 Society for...
SAN FRANCISCO Oct. 28 2016 PRNewswire Nektar Therapeutics Nasdaq NKTR today announced five data presentations will be delivered at the upcoming Society for Immunotherapy of Cancer SITC Annual Meeting...
View ArticleNektar to Hold Investor & Analyst Event at 2016 Society for Immunotherapy of...
SAN FRANCISCO Oct. 28 2016 PRNewswire Nektar Therapeutics Nasdaq NKTR today announced that it will host an investor and analyst event at the upcoming Society for Immunotherapy of Cancer SITC 2016...
View ArticleTxCell TXCL Increasing CAR Treg emphasis
Edison Investment Research Pharmaceutical & healthcare TxCell TxCell&8217;s new and novel CARmodified regulatory Tcell CAR Treg platform has developed rapidly since June with three key academic...
View ArticleBreast microbiome different in women with cancer
Much of the news on this topicÂhas been aboutÂthe colony of bacteria deep in your gut; scientists believe that the mix may contribute to all sorts of medical conditions including from Crohns disease an...
View ArticleMayne Pharma Launches Budesonide Capsules in the United States
Greenville NC October 29 2016 PR.com Mayne Pharma Inc. Mayne Pharma is pleased to announce the U.S. launch of budesonide capsules a generic version of branded Entocort EC&174; which is used to...
View ArticleNovartis Wins Two Prestigious Prix Galien Foundation Awards; GleevecÂ...
Novartis International AG Novartis Wins Two Prestigious Prix Galien Foundation Awards; Gleevec recognized as "Discovery of the Decade" for Best Pharmaceutical Product Cosentyx as...
View ArticleArena Pharmaceuticals to Release Third Quarter 2016 Financial Results and...
SAN DIEGO Oct. 31 2016 PRNewswire Arena Pharmaceuticals Inc. NASDAQ ARNA today announced that the Company will release its third quarter 2016 financial results and provide a corporate update on Monday...
View ArticleMedical Marijuana Inc. Portfolio Company AXIM Biotech Begins PKPD Studies...
NEW YORK NY Marketwired November 01 2016 Medical Marijuana Inc. OTC MJNA today announced that its portfolio company AXIMÂ Biotechnologies Inc. AXIMÂ Biotech OTC AXIM has begun...
View ArticleRedHill Biopharma to Host Investor Conference Call Today at 1800 EDT...
TELAVIV Israel Nov. 01 2016 GLOBE NEWSWIRE RedHill Biopharma Ltd. NASDAQRDHL TASERDHL "RedHill" or the "Company" a biopharmaceutical company primarily focused on the...
View ArticleGilead to drop simtuzumab and Crohns Disease treatment
US biopharmaceutical giant Gilead Sciences NASDAQGILD will drop simtuzumab from the ongoing development of its fatty liver disease treatment GS4997.Gilead announced a couple of weeks ago that it would...
View ArticleNovartis Wins Two Prestigious Prix Galien Foundation Awards
Gleevec recognized as Discovery of the Decade for Best Pharmaceutical Product Cosentyx as Best Biotechnology ProductSOURCE NovartisDESCRIPTIONBasel November 2 2016 3BL MediaÂÂNovartis has been...
View ArticleRedHill Biopharma Announces Withdrawal of Public Offering of its American...
TELAVIV Israel Nov. 02 2016 GLOBE NEWSWIRE RedHill Biopharma Ltd. NASDAQRDHL TASERDHL "RedHill" or the "Company" a biopharmaceutical company primarily focused on the...
View Article